Panretinal (Scatter) Laser Photocoagulation

Medicare covers panretinal (scatter) laser photocoagulation for management of proliferative and pre-proliferative retinopathies, including severe diabetic macular edema associated with pre-proliferative retinopathy, and other proliferative retinopathies when treatment is clinically justified. Initial PRP typically involves ~1500–2000 laser spots delivered over two or more staged sessions; payment is allowed once during the global period and subsequent postoperative sessions are included in the initial allowance, and non-physician practitioners are not reimbursed for performing the procedure.

"Panretinal laser photocoagulation (PRP) is indicated for treatment or management of proliferative diabetic retinopathy (PDR)."

Sign up to see full coverage criteria, indications, and limitations.